TNDM Tandem Diabetes Care Inc

Price (delayed)

$94.67

Market cap

$5.89B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.8

Enterprise value

$5.98B

Sector: Healthcare
Industry: Medical Devices

Tandem Diabetes Care is a public US medical device manufacturer based in San Diego, CA. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy. ...

Highlights

Tandem Diabetes Care's quick ratio has soared by 143% YoY and by 19% from the previous quarter
The company's equity has surged by 96% YoY and by 22% QoQ
The net income has plunged by 105% YoY and by 15% from the previous quarter
Tandem Diabetes Care's EPS has decreased by 14% from the previous quarter

Key stats

What are the main financial stats of TNDM
Market
Shares outstanding
62.19M
Market cap
$5.89B
Enterprise value
$5.98B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
17.66
Price to sales (P/S)
13.26
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.63
Earnings
Revenue
$439.16M
EBIT
-$42.51M
EBITDA
-$33.85M
Free cash flow
-$1.19M
Per share
EPS
-$0.8
Free cash flow per share
-$0.02
Book value per share
$5.36
Revenue per share
$7.14
TBVPS
$10.94
Balance sheet
Total assets
$672.99M
Total liabilities
$346.44M
Debt
$226.38M
Equity
$326.54M
Working capital
$486.79M
Liquidity
Debt to equity
0.69
Current ratio
5.61
Quick ratio
4.9
Net debt/EBITDA
-2.86
Margins
EBITDA margin
-7.7%
Gross margin
52.4%
Net margin
-11.1%
Operating margin
-5.6%
Efficiency
Return on assets
-10%
Return on equity
-19.6%
Return on invested capital
-10.9%
Return on capital employed
-7.5%
Return on sales
-9.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TNDM stock price

How has the Tandem Diabetes Care stock price performed over time
Intraday
-1.41%
1 week
4.32%
1 month
-17.86%
1 year
48.53%
YTD
58.82%
QTD
-16.59%

Financial performance

How have Tandem Diabetes Care's revenue and profit performed over time
Revenue
$439.16M
Gross profit
$230.24M
Operating income
-$24.48M
Net income
-$48.73M
Gross margin
52.4%
Net margin
-11.1%
The net income has plunged by 105% YoY and by 15% from the previous quarter
The net margin has plunged by 54% YoY and by 8% from the previous quarter
The operating income fell by 34% YoY but it rose by 17% QoQ
TNDM's revenue is up by 33% year-on-year and by 7% since the previous quarter

Growth

What is Tandem Diabetes Care's growth rate over time

Valuation

What is Tandem Diabetes Care stock price valuation
P/E
N/A
P/B
17.66
P/S
13.26
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.63
Tandem Diabetes Care's EPS has decreased by 14% from the previous quarter
The company's equity has surged by 96% YoY and by 22% QoQ
TNDM's price to book (P/B) is 12% less than its last 4 quarters average of 20.0
The P/S is 87% higher than the 5-year quarterly average of 7.1 and 6% higher than the last 4 quarters average of 12.5
TNDM's revenue is up by 33% year-on-year and by 7% since the previous quarter

Efficiency

How efficient is Tandem Diabetes Care business performance
The return on invested capital has increased by 39% year-on-year and by 29% since the previous quarter
Tandem Diabetes Care's ROS has decreased by 37% YoY but it has increased by 3% from the previous quarter
TNDM's ROE is down by 17% YoY but it is up by 3% from the previous quarter
The return on assets has increased by 7% since the previous quarter but it has declined by 2% year-on-year

Dividends

What is TNDM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNDM.

Financial health

How did Tandem Diabetes Care financials performed over time
The total assets is 94% greater than the total liabilities
Tandem Diabetes Care's quick ratio has soared by 143% YoY and by 19% from the previous quarter
The total assets has surged by 130% year-on-year and by 9% since the previous quarter
The debt is 31% less than the equity
The company's equity has surged by 96% YoY and by 22% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.